HDJ François Villon
Cergy-Pontoise, 95303, France
NCT Number: NCT03225027
The purpose of the present study is to evaluate the effect of emotional prosody on the perception of emotional discourse in the schizophrenic spectrum. The investigators hypothesize that participant may use emotional prosody as an emotional cue to understand the emotional content of discourse.
Looking for future studies?
Notify Me18 year–60 year
All sexes
Interventional
Not applicable
Cergy-Pontoise, 95303, France
The integration of ortholinguistic and paralinguistic functions in language, particularly of the emotional prosody, is necessary to interact adaptively with others. People in the schizophrenic spectrum have social difficulties. Is emotional prosody comprehension altered in these people? According to Edwards et al. (2002), there is methodological issues concerning the tasks used to answer this question. Investigators built an emotional judgment task more adapted to study the perception of emotional prosody in the schizophrenic spectrum than the classical paradigm designed to evaluate participants with cerebral injury. The investigators have elaborated a material that consists of 140 short sentences (7±2 words) with a simple syntactic structure. The verbal content expressed positive, neutral or negative emotions. These sentences were announced by four professional actors (two female) with an emotional prosody content congruent or inconsistent with the verbal content. Participants will have to evaluate the emotional intensity of the recordings on a five points Likert scale, from strongly negative to strongly positive. Psychotic experiences of all participants will be evaluated too.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Non-inclusion Criteria:
Exclusion criteria
Participants had to indicate on a computer the emotional intensity of audio recordings.
Participants will be invited to give us the cognitive strategy used to resolve the emotional judgment task.
Participants will be invited to indicate which recordings they had heard during the emotional judgment task to verify that they have paid attention to the emotional task.
Participants indicate every time they heard a given sound in order to verify their audition level.
This questionnaire allows evaluating the nature of psychotic experiences.
To evaluate their emotional intelligence.
Other names: TEIQUE
Evaluating the clinical status of patients with schizophrenia.
Other names: PANSS
Evaluating the exclusion criteria in healthy participants.
Other names: MINI
Time frame: During the experiment
Participants will have to judge the emotional intensity of audio recordings. In this task, the participant is asked to judge the emotional intensity of audio recordings of men and women (2 actors + 2 actresses): he / she must press a button as quickly as possible to indicate whether the Audio recordings presented via small speakers are very negative, negative, non-emotional, positive or very positive (5 possible choices).
The response time variable may be added as a co-variable in order to avoid perceptive-motor disorders (medication-related and / or general motor slowdown) that may influence the results of time-of- answers.
Time frame: During the experiment
Evaluate the nature of the psychotic experiments (CAPE-42 test).
Time frame: During the experiment
Neuropsychological tests will allow evaluating the cognitive profile of the participants that can impact their behaviour during the experiment.
Hôpital NOVO
Other
Acronym: SKYPROVERB
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05838573
Cognition Disorders, Cognitive Dysfunction
Changsha, Hunan, China
View Trial DetailsNCT06627413
Mental Disorders, Schizophrenia
Los Alamitos, California, United States
View Trial DetailsNCT05304767
Mental Disorders, Schizophrenia
Phoenix, Arizona, United States
View Trial DetailsNCT07190352
Mental Disorders, Nicotine Use
Boston, Massachusetts, United States
View Trial Details